Biotech Company That Botched Vaccines Faces Investor Revolt


By BY CHRIS HAMBY
U.S.
https://ift.tt/3jIVg2k
In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’ request.
New York Times
Stocks and Bonds, Suits and Litigation (Civil), Vaccination and Immunization, Factories and Manufacturing, Securities and Commodities Violations, Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), Shareholder Rights and Activism
July 6, 2021 at 07:00AM

Popular posts from this blog

Why Do We Think It's Okay to Invade Strangers' Privacy?

Why American Spies Worry When Trump Meets Putin